Study of GS-3242 in Participants With HIV-1; Substudy-05
Completed · Phase 1
Conditions studied: HIV-1-infection
In brief
This study is part of a master study. The goal of master protocol (GS-US-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Substudy GS-US-544-5905-05 is to learn more about the study drug GS-3242 in PWH.
Key facts
- Study ID
- NCT07001319
- Run by
- Gilead Sciences
- People needed
- 27
- Starts
- 2025-05-29
- Expected to finish
- 2026-04-16
- Last updated by the study team
- 2026-05-11
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Franco Felizarta, MD — Bakersfield, California, United States
- Ruane Clinical Research Group, Inc — Los Angeles, California, United States
- Mills Clinical Research — Los Angeles, California, United States
- Quest Clinical Research — San Francisco, California, United States
- Washington Health Institute — Washington D.C., District of Columbia, United States
- Midland Florida Clinical Research Center, LLC — DeLand, Florida, United States
- AIDS Healthcare Foundation - Northpoint — Fort Lauderdale, Florida, United States
- Midway Immunology & Research Center, LLC — Ft. Pierce, Florida, United States
- BLISS Health — Orlando, Florida, United States
- Orlando Immunology Center, PA — Orlando, Florida, United States
- Triple O Research Institute, P.A. — West Palm Beach, Florida, United States
- Chatham County Health Department — Savannah, Georgia, United States
- Indiana University School of Medicine — Indianapolis, Indiana, United States
- Be Well Medical Center — Berkley, Michigan, United States
- KC CARE Health Center — Kansas City, Missouri, United States
- University of Cincinnati College of Medicine — Cincinnati, Ohio, United States
- Central Texas Clinical Research — Austin, Texas, United States
- Prism Health North Texas — Dallas, Texas, United States
- North Texas Infectious Diseases Consultant's, P.A. — Dallas, Texas, United States
- AXCES Research Group, LLC — El Paso, Texas, United States
- AXCES Research Group, LLC — Salt Lake City, Utah, United States
- ProcliniQ Investigación Clínica S.A. de C.V — Mexico City, Mexico
- Institute of HIV Research and Innovation (IHRI) — Bangkok, Thailand
- Faculty of Medicine Ramathibodi Hospital, Mahidol University — Bangkok, Thailand
- Faculty of Medicine Siriraj Hospital, Mahidol University — Bangkok, Thailand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.